Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Irritable Bowel Syndrome, August 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 96 articles:
HTML format


 

Single Articles

  1. WILLIAMS CE, Williams EA, Corfe BM
    Vitamin D supplementation in people with IBS has no effect on symptom severity and quality of life: results of a randomised controlled trial.
    Eur J Nutr. 2021 Jul 30. pii: 10.1007/s00394-021-02633.
    PubMed    
    Abstract available

  2. GADOUR E, Hassan Z, Gadour R
    A Comprehensive Review of Transaminitis and Irritable Bowel Syndrome.
    Cureus. 2021;13:e16583.
    PubMed    
    Abstract available

  3. BLAKEY SM, Halverson TF, Evans MK, Patel TA, et al
    Experiential avoidance is associated with medical and mental health diagnoses in a national sample of deployed Gulf War veterans.
    J Psychiatr Res. 2021;142:17-24.
    PubMed    
    Abstract available

  4. GACESA R, Vich Vila A, Collij V, Mujagic Z, et al
    A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease.
    Gut Microbes. 2021;13:1943288.
    PubMed    
    Abstract available

  5. XU S, Chen C, Ouyang Z, Duan C, et al
    Association between multiple sleep dimensions and functional bowel disorders among Chinese college freshmen.
    Sleep Med. 2021 May 21. pii: S1389-9457(21)00294.
    PubMed    
    Abstract available

  6. GUO X, Xuan M, Zheng H, Qin S, et al
    The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial.
    Trials. 2021;22:491.
    PubMed    
    Abstract available

  7. PETERSEN MW, Skovbjerg S, Jensen JS, Carstensen T, et al
    Conditioned pain modulation and pain sensitivity in functional somatic disorders: The DanFunD study.
    Eur J Pain. 2021 Jul 26. doi: 10.1002/ejp.1847.
    PubMed    
    Abstract available

  8. SU XT, Wang LQ, Zhang N, Li JL, et al
    Standardizing and optimizing acupuncture treatment for irritable bowel syndrome: A Delphi expert consensus study.
    Integr Med Res. 2021;10:100728.
    PubMed    
    Abstract available

  9. CARMONA-SANCHEZ R, Carrera-Alvarez MA, Pena-Zepeda C
    Prevalence of primary eosinophilic colitis in patients with chronic diarrhea and diarrhea-predominant irritable bowel syndrome.
    Rev Gastroenterol Mex (Engl Ed). 2021 Jul 22. pii: S2255-534X(21)00075.
    PubMed    
    Abstract available

  10. BARJANDI G, Kosek E, Hedenberg-Magnusson B, Velly AM, et al
    Comorbid Conditions in Temporomandibular Disorders Myalgia and Myofascial Pain Compared to Fibromyalgia.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  11. ZEJNELAGIC J, Ohlsson B
    Chronic stress and poor sleeping habits are associated with self-reported IBS and poor psychological well-being in the general population.
    BMC Res Notes. 2021;14:280.
    PubMed    
    Abstract available

  12. MAHANTSHETTY U, Poetter R, Beriwal S, Grover S, et al
    IBS-GEC ESTRO-ABS Recommendations for CT Based Contouring in Image Guided Adaptive Brachytherapy for Cervical cancer.
    Radiother Oncol. 2021 May 17. pii: S0167-8140(21)06248.
    PubMed    
    Abstract available

  13. JUNG HJ, Priefer R
    Tachykinin NK2 antagonist for treatments of various disease states.
    Auton Neurosci. 2021;235:102865.
    PubMed    
    Abstract available

  14. STENLUND H, Nilholm C, Chorell E, Roth B, et al
    Metabolic Profiling of Plasma in Patients with Irritable Bowel Syndrome after a 4-Week Starch- and Sucrose-Reduced Diet.
    Metabolites. 2021;11.
    PubMed    
    Abstract available

  15. KIM MY, Choi SW
    Dietary modulation of gut microbiota for the relief of irritable bowel syndrome.
    Nutr Res Pract. 2021;15:411-430.
    PubMed    
    Abstract available

  16. ALVIZURI GOMEZ CM, Bellido Caparo A, Samalvides Cuba F, Pinto Valdivia JL, et al
    Epidemiology and associated factors of irritable bowel syndrome in an Andean community from Peru.
    Rev Gastroenterol Peru. 2021;41:6-10.
    PubMed    
    Abstract available

  17. ENGEL F, Stadnitski T, Stroe-Kunold E, Berens S, et al
    Pain and psyche in a patient with irritable bowel syndrome: chicken or egg? A time series case report.
    BMC Gastroenterol. 2021;21:309.
    PubMed    
    Abstract available

  18. SINGH P, Ballou S, Rangan V, Katon J, et al
    Clinical and psychological factors predict outcome in patients with Functional Dyspepsia: A prospective study.
    Clin Gastroenterol Hepatol. 2021 Jul 30. pii: S1542-3565(21)00825.
    PubMed    
    Abstract available

  19. ARISHI AM, Elmakki EE, Hakami OM, Alganmy OM, et al
    Irritable Bowel Syndrome: Prevalence and Risk Factors in Jazan Region, Saudi Arabia.
    Cureus. 2021;13:e15979.
    PubMed    
    Abstract available

  20. ATEFI M, Darand M, Entezari MH, Jamialahmadi T, et al
    A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases.
    Adv Exp Med Biol. 2021;1291:295-326.
    PubMed    
    Abstract available

  21. TUCK CJ, Malakar S, Barrett JS, Muir JG, et al
    Naturally-occurring dietary salicylates in the genesis of functional gastrointestinal symptoms in patients with irritable bowel syndrome: Pilot study.
    JGH Open. 2021;5:871-878.
    PubMed    
    Abstract available

  22. ZHENG H, Jin S, Shen YL, Peng WY, et al
    Chinese Herbal Medicine for Irritable Bowel Syndrome: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.
    Front Pharmacol. 2021;12:694741.
    PubMed    
    Abstract available

  23. TRAMULLAS M, Collins JM, Fitzgerald P, Dinan TG, et al
    Estrous cycle and ovariectomy-induced changes in visceral pain are microbiota-dependent.
    iScience. 2021;24:102850.
    PubMed    
    Abstract available

  24. MATSUMOTO K, Takata K, Yamada D, Usuda H, et al
    Juvenile social defeat stress exposure favors in later onset of irritable bowel syndrome-like symptoms in male mice.
    Sci Rep. 2021;11:16276.
    PubMed    
    Abstract available

  25. KAILOO S, Shreya, Kumar Y
    Cytolethal distending toxin: from genotoxin to a potential biomarker and anti-tumor target.
    World J Microbiol Biotechnol. 2021;37:150.
    PubMed    
    Abstract available

  26. ADAM RD
    Giardia duodenalis: Biology and Pathogenesis.
    Clin Microbiol Rev. 2021 Aug 11:e0002419. doi: 10.1128/CMR.00024.
    PubMed    
    Abstract available

  27. GUBATAN J, Zikos T, Spear Bishop E, Wu J, et al
    Gastrointestinal symptoms and healthcare utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID-19 pandemic.
    Neurogastroenterol Motil. 2021 Aug 11:e14243. doi: 10.1111/nmo.14243.
    PubMed    
    Abstract available

  28. HEITMANN PT, Vollebregt PF, Knowles CH, Lunniss PJ, et al
    Understanding the physiology of human defaecation and disorders of continence and evacuation.
    Nat Rev Gastroenterol Hepatol. 2021 Aug 9. pii: 10.1038/s41575-021-00487.
    PubMed    
    Abstract available

  29. PROSPERO L, Riezzo G, Linsalata M, Orlando A, et al
    Psychological and Gastrointestinal Symptoms of Patients with Irritable Bowel Syndrome Undergoing a Low-FODMAP Diet: The Role of the Intestinal Barrier.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  30. HAHN J, Choi J, Chang MJ
    Effect of Low FODMAPs Diet on Irritable Bowel Syndromes: A Systematic Review and Meta-Analysis of Clinical Trials.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  31. GUO J, Sun JH, Chen L, Geng H, et al
    [Bidirectional regulation of acupuncture: a subgroup analysis of multicenter randomized controlled trial of acupuncture with Tiaoshen Jianpi for irritable bowel syndrome].
    Zhongguo Zhen Jiu. 2021;41:845-50.
    PubMed    
    Abstract available

  32. NORDSTROM EA, Teixeira C, Montelius C, Jeppsson B, et al
    Lactiplantibacillus plantarum 299v (LP299V((R))): three decades of research.
    Benef Microbes. 2021 Aug 9:1-26. doi: 10.3920/BM2020.0191.
    PubMed    
    Abstract available

  33. PETERS JE, Kamm MA, Basnayake C
    Approach to Dietary Restriction in Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2021 Aug 5. pii: S1542-3565(21)00837.
    PubMed    


  34. GROS M, Gros B, Mesonero JE, Latorre E, et al
    Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  35. FERNANDEZ-BANARES F, Arau B, Raga A, Aceituno M, et al
    Long-Term Effect of a Gluten-Free Diet on Diarrhoea- or Bloating-Predominant Functional Bowel Disease: Role of the 'Low-Grade Coeliac Score' and the 'Coeliac Lymphogram' in the Response Rate to the Diet.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  36. OHLSSON B
    Theories behind the effect of starch and sucrosereduced diets on gastrointestinal symptoms in irritable bowel syndrome (Review).
    Mol Med Rep. 2021;24.
    PubMed    
    Abstract available

  37. FETTUCCIARI K, Marconi P, Marchegiani A, Fruganti A, et al
    Invisible steps for a global endemy: molecular strategies adopted by Clostridioides difficile.
    Therap Adv Gastroenterol. 2021;14:17562848211032797.
    PubMed    
    Abstract available

  38. BELLINI M, Berti G, Bonfrate L, Ciranni F, et al
    Use of GELSECTAN((R)) in Patients with Irritable Bowel Syndrome (IBS): an Italian Experience.
    Patient Prefer Adherence. 2021;15:1763-1774.
    PubMed    
    Abstract available

  39. AHMED S, Newton PD, Ojo O, Dibley L, et al
    Experiences of ethnic minority patients who are living with a primary chronic bowel condition: a systematic scoping review with narrative synthesis.
    BMC Gastroenterol. 2021;21:322.
    PubMed    
    Abstract available

  40. FAN F, Chen Y, Chen Z, Guan L, et al
    Blockade of BK channels attenuates chronic visceral hypersensitivity in an IBS-like rat model.
    Mol Pain. 2021;17:17448069211040364.
    PubMed    
    Abstract available

  41. WILLIAMS MO, Sedarous M, Dennis B, Dlamini V, et al
    The fragility of randomized placebo-controlled trials for irritable bowel syndrome.
    Neurogastroenterol Motil. 2021;33:e14166.
    PubMed    
    Abstract available

  42. SAUL S, Fuessel J, Runde J
    Pediatric Digestive Health and the Gut Microbiome: Existing Therapies and a Look to the Future.
    Pediatr Ann. 2021;50:e336-e342.
    PubMed    
    Abstract available

  43. OSAREH F, Ghazavi R, Adibi P
    Information retrieval strategy in functional gastrointestinal disorders with emphasis on the sensitivity and precision.
    J Educ Health Promot. 2021;10:207.
    PubMed    
    Abstract available

  44. CUI J, Lin Z, Tian H, Yang B, et al
    Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study.
    Front Med (Lausanne). 2021;8:710452.
    PubMed    
    Abstract available

  45. FRIESEN C, Colombo JM, Deacy A, Schurman JV, et al
    An Update on the Assessment and Management of Pediatric Abdominal Pain.
    Pediatric Health Med Ther. 2021;12:373-393.
    PubMed    
    Abstract available

  46. QUAGHEBEUR J, Petros P, Wyndaele JJ, De Wachter S, et al
    The innervation of the bladder, the pelvic floor, and emotion: A review.
    Auton Neurosci. 2021;235:102868.
    PubMed    
    Abstract available

  47. OROCK A, Louwies T, Ligon CO, Mohammadi E, et al
    Environmental enrichment prevents stress-induced epigenetic changes in the expression of glucocorticoid receptor and corticotrophin releasing hormone in the central nucleus of the amygdala to inhibit visceral hypersensitivity.
    Exp Neurol. 2021;345:113841.
    PubMed    
    Abstract available

  48. VASAPOLLI R, Schulz C, Schweden M, Casen C, et al
    Gut Microbiota Profiles and the Role of Anti-CdtB and Anti-vinculin Antibodies in Patients with FGID.
    Eur J Clin Invest. 2021 Aug 14:e13666. doi: 10.1111/eci.13666.
    PubMed    
    Abstract available

  49. LIN L, Wyness SP, Jensen R, Bird J, et al
    Comparison of Next-Generation Assays for Fecal Calprotectin vs the PhiCal Assay.
    Am J Clin Pathol. 2021 Aug 14. pii: 6352409. doi: 10.1093.
    PubMed    
    Abstract available

  50. LYNCH E, Troob J, Lebwohl B, Freedberg DE, et al
    Who uses probiotics and why? A survey study conducted among general gastroenterology patients.
    BMJ Open Gastroenterol. 2021;8.
    PubMed    
    Abstract available

  51. SALINAS E, Reyes-Pavon D, Cortes-Perez NG, Torres-Maravilla E, et al
    Bioactive Compounds in Food as a Current Therapeutic Approach to Maintain a Healthy Intestinal Epithelium.
    Microorganisms. 2021;9.
    PubMed    
    Abstract available

  52. KARLUND A, Paukkonen I, Gomez-Gallego C, Kolehmainen M, et al
    Intestinal Exposure to Food-Derived Protease Inhibitors: Digestion Physiology- and Gut Health-Related Effects.
    Healthcare (Basel). 2021;9.
    PubMed    
    Abstract available

  53. LE MORVAN DE SEQUEIRA C, Kaeber M, Cekin SE, Enck P, et al
    The Effect of Probiotics on Quality of Life, Depression and Anxiety in Patients with Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  54. BOECK T, Zannini E, Sahin AW, Bez J, et al
    Nutritional and Rheological Features of Lentil Protein Isolate for Yoghurt-Like Application.
    Foods. 2021;10.
    PubMed    
    Abstract available

  55. CHLEBICZ-WOJCIK A, Slizewska K
    Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review.
    Biomolecules. 2021;11.
    PubMed    
    Abstract available

  56. MCEVOY MA, Attia JR, Oldmeadow C, Holliday E, et al
    Serum L-arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case-control study.
    United European Gastroenterol J. 2021 Aug 25. doi: 10.1002/ueg2.12137.
    PubMed    
    Abstract available

  57. MCPHERSON ZE, Sorensen HT, Horvath-Puho E, Agar A, et al
    Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population-based cohort studies.
    United European Gastroenterol J. 2021 Aug 25. doi: 10.1002/ueg2.12136.
    PubMed    
    Abstract available

  58. GARDINER CP, Singh P, Ballou S, Hassan R, et al
    Symptom severity and clinical characteristics of patients with bloating.
    Neurogastroenterol Motil. 2021 Aug 24:e14229. doi: 10.1111/nmo.14229.
    PubMed    
    Abstract available

  59. STAUDACHER HM, Rossi M, Kaminski T, Dimidi E, et al
    Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome.
    Neurogastroenterol Motil. 2021 Aug 24:e14241. doi: 10.1111/nmo.14241.
    PubMed    
    Abstract available

  60. TANG HY, Jiang AJ, Wang XY, Wang H, et al
    Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review.
    Ann Transl Med. 2021;9:1187.
    PubMed    
    Abstract available

  61. BARBERIO B, Savarino EV, Black CJ, Ford AC, et al
    Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome with Constipation or Diarrhea: Meta-Analysis.
    Clin Gastroenterol Hepatol. 2021 Aug 20. pii: S1542-3565(21)00905.
    PubMed    
    Abstract available

  62. JIANG Y, Castro J, Blomster LV, Agwa AJ, et al
    Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome.
    ACS Pharmacol Transl Sci. 2021;4:1362-1378.
    PubMed    
    Abstract available

  63. AVORIO F, Cerulli Irelli E, Morano A, Fanella M, et al
    Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence.
    Front Neurol. 2021;12:705126.
    PubMed    
    Abstract available

  64. LU Z, Xu Y, Song Y, Biro I, et al
    A Mixed Comparisons of Different Intensities and Types of Physical Exercise in Patients With Diseases Related to Oxidative Stress: A Systematic Review and Network Meta-Analysis.
    Front Physiol. 2021;12:700055.
    PubMed    
    Abstract available

  65. STALLER K, Olen O, Soderling J, Roelstraete B, et al
    Diagnostic yield of endoscopy in irritable bowel syndrome: A nationwide prevalence study 1987-2016.
    Eur J Intern Med. 2021 Aug 19. pii: S0953-6205(21)00267.
    PubMed    
    Abstract available

  66. MISERY L, Shourick J, Reychler G, Taieb C, et al
    Association between chronic idiopathic cough and sensitive skin syndromes is a new argument in favor of common neuropathic pathways: results from a survey on 4050 subjects.
    Sci Rep. 2021;11:16976.
    PubMed    
    Abstract available

  67. AKBANI U, Vasant DH
    Editorial: important insights into prescribing practices and training needs of gastroenterologists regarding use of central neuromodulators in IBS.
    Aliment Pharmacol Ther. 2021;54:339-340.
    PubMed    


  68. VASANT DH
    Editorial: recognising the efficacy of licensed drug therapies for IBS on bloating-a step in the right direction for targeted treatment?
    Aliment Pharmacol Ther. 2021;54:196-197.
    PubMed    


  69. NEE J, Ballou S, Kelley JM, Kaptchuk TJ, et al
    Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 Jul 28. pii: 00000434-990000000-00060.
    PubMed    
    Abstract available

  70. DEUTSCH D, Bouchoucha M, Uzan J, Raynaud JJ, et al
    Abdominal Pain Severity Is Mainly Associated with Bloating Severity in Patients with Functional Bowel Disorders and Functional Abdominal Pain.
    Dig Dis Sci. 2021 Jul 29. pii: 10.1007/s10620-021-07175.
    PubMed    
    Abstract available

  71. LEVINTHAL DJ
    Now Trending: Using Google Trends to Complement Traditional Epidemiological Methods Used for IBS Research.
    Dig Dis Sci. 2021;66:662-664.
    PubMed    


  72. SHAH A, Gurusamy SR, Hansen T, Callaghan G, et al
    Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07149.
    PubMed    
    Abstract available

  73. CHUAH KH, Wong MS, Tan PO, Lim SZ, et al
    Small Intestinal Bacterial Overgrowth In Various Functional Gastrointestinal Disorders: A Case-Control Study.
    Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07227.
    PubMed    
    Abstract available

  74. CHEY WD
    Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2021;50:xv-xvi.
    PubMed    


  75. BERRY SK, Chey WD
    Integrated Care for Irritable Bowel Syndrome: The Future Is Now.
    Gastroenterol Clin North Am. 2021;50:713-720.
    PubMed    
    Abstract available

  76. PEREZ DE ARCE E, Quera R, Quigley EMM
    The Dilemma of Persistent Irritable Bowel Syndrome Symptoms in Patients with Quiescent Inflammatory Bowel Disease.
    Gastroenterol Clin North Am. 2021;50:689-711.
    PubMed    
    Abstract available

  77. SHAPIRO JM, Deutsch JK
    Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2021;50:671-688.
    PubMed    
    Abstract available

  78. TORNBLOM H, Drossman DA
    Psychopharmacologic Therapies for Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2021;50:655-669.
    PubMed    
    Abstract available

  79. LIU JJ, Brenner DM
    Focus on Pharmacotherapy for Irritable Bowel Syndrome with Constipation.
    Gastroenterol Clin North Am. 2021;50:639-653.
    PubMed    
    Abstract available

  80. SAYUK GS
    Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2021;50:611-637.
    PubMed    
    Abstract available

  81. MCGOWAN A, Harer KN
    Irritable Bowel Syndrome and Eating Disorders: A Burgeoning Concern in Gastrointestinal Clinics.
    Gastroenterol Clin North Am. 2021;50:595-610.
    PubMed    
    Abstract available

  82. JAGIELSKI CH, Riehl ME
    Behavioral Strategies for Irritable Bowel Syndrome: Brain-Gut or Gut-Brain?
    Gastroenterol Clin North Am. 2021;50:581-593.
    PubMed    
    Abstract available

  83. HALLER E, Scarlata K
    Diet Interventions for Irritable Bowel Syndrome: Separating the Wheat from the Chafe.
    Gastroenterol Clin North Am. 2021;50:565-579.
    PubMed    
    Abstract available

  84. GOLDSTEIN RS, Cash BD
    Making a Confident Diagnosis of Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2021;50:547-563.
    PubMed    
    Abstract available

  85. SINGH P, Lembo A
    Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2021;50:523-545.
    PubMed    
    Abstract available

  86. VIDELOCK EJ, Chang L
    Latest Insights on the Pathogenesis of Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2021;50:505-522.
    PubMed    
    Abstract available

  87. SPERBER AD
    Epidemiology and Burden of Irritable Bowel Syndrome: An International Perspective.
    Gastroenterol Clin North Am. 2021;50:489-503.
    PubMed    
    Abstract available

  88. GUNN D, Abbas Z, Harris HC, Major G, et al
    Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies.
    Gut. 2021 Aug 5. pii: gutjnl-2021-324784. doi: 10.1136/gutjnl-2021-324784.
    PubMed    
    Abstract available

  89. BLACK CJ, Staudacher HM, Ford AC
    Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis.
    Gut. 2021 Aug 10. pii: gutjnl-2021-325214. doi: 10.1136/gutjnl-2021-325214.
    PubMed    
    Abstract available

  90. SO D, Gibson PR, Muir JG, Yao CK, et al
    Dietary fibres and IBS: translating functional characteristics to clinical value in the era of personalised medicine.
    Gut. 2021 Aug 20. pii: gutjnl-2021-324891. doi: 10.1136/gutjnl-2021-324891.
    PubMed    
    Abstract available

  91. CAMILLERI M
    FMT in IBS: a call for caution.
    Gut. 2021;70:431.
    PubMed    


  92. EBEID B, Eid RA, Attia D, Daoud SA, et al
    Prevalence of Microscopic Colitis in Diarrhea-predominant Irittable Bowel Syndrome Patients: Cohort Study From Upper Egypt.
    J Clin Gastroenterol. 2021 Jul 30. pii: 00004836-900000000-97383.
    PubMed    
    Abstract available

  93. BAKKE I, Walaas GA, Bruland T, Royset ES, et al
    Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis.
    J Gastroenterol. 2021 Aug 19. pii: 10.1007/s00535-021-01814.
    PubMed    
    Abstract available

  94. WANG XY, Wang H, Guan YY, Cai RL, et al
    Acupuncture for functional gastrointestinal disorders: a systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2021 Aug 3. doi: 10.1111/jgh.15645.
    PubMed    
    Abstract available

  95. WU YB, Dai YK, Zhang L, Pan HG, et al
    Pharmacological treatments of Chinese herbal medicine for irritable bowel syndrome in adults: A network meta-analysis of randomized controlled trials.
    PLoS One. 2021;16:e0255665.
    PubMed    
    Abstract available

  96. XU HL, Zou LL, Chen MB, Wang H, et al
    Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0255160.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;